| ASCENDIS PHARMA ADR |
| USA |
| Gesundheit |
| US04351P1012 / A14M6X |
| A71 (Frankfurt) / ASND (NASDAQ) |
| FRA:A71, ETR:A71, A71:GR, NASDAQ:ASND |
| - |
| https://ascendispharma.co.. |
|
Ascendis Pharma is a global biopharmaceutical company headquartered in Copenhagen, Denmark, specializing in the development of innovative therapies using its proprietary TransCon technology platform. The company focuses on addressing unmet medical ne..
>Volltext.. |
| 11588.1 Mio. EUR |
| 11847.8 Mio. EUR |
| 711.69 Mio. EUR |
| -108.38 Mio. EUR |
| -219.59 Mio. EUR |
| -3.63 EUR |
| 885.27 Mio. EUR |
| 625.57 Mio. EUR |
| 52.79 Mio. EUR |
| 0.58 |
| 110.04% |
| 38.05% |
| - |
| - |
| - |
| - |
| ASCENDIS |
| 02.04.26 |
|
||||
|